skip to Main Content

“Medicaid programs will likely face major budget impacts from emerging cell and gene therapies.”
Amelia Nell
Amelia Nell
Associate
0%
of Medicare patients with breast cancer taking a medicine covered by Medicare Part B received a therapy that was not routinely covered by England’s NHS or its CDF.
“The evidence is becoming clearer that SDOH impact utilization of health services.”
Christie Teigland
Christie Teigland
Principal
0%
of FFS Medicare enrollees have stated they are forgoing non-COVID-19 related care due to the pandemic.
Back To Top